The report provides comprehensive information on the therapeutics under development for Ovarian Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects.The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
- The report provides a snapshot of the global therapeutic landscape of Ovarian Cancer
- The report reviews pipeline therapeutics for Ovarian Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Ovarian Cancer therapeutics and enlists all their major and minor projects
- The report assesses Ovarian Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Ovarian Cancer
- 3-V Biosciences, Inc.
- 4SC AG
- AB Science SA
- AbbVie Inc.
- AbGenomics International, Inc.
- Acetylon Pharmaceuticals, Inc.
- Aphios Corporation
- Aposense Ltd.
- Aprea AB
- Bavarian Nordic A/S
- Bayer AG
- BeiGene, Ltd.
- BioCancell Ltd
- Pangaea Biotech, S.L.
- Panther Biotechnology, Inc.
- PDS Biotechnology Corporation
- PEP-Therapy SAS
- PsiOxus Therapeutics Limited
- TaiRx, Inc.
- Takeda Pharmaceutical Company Limited
- Takis S.r.l.
Please find more about Ovarian Cancer - Pipeline Review, H1 2016 at reports.zursh.com
Click on below items to see free updates about the topic covered.
Click on below items to see free resources and reports about the topic covered.